A mucosal vaccination approach for herpes simplex virus type 2

This publication has 43 references indexed in Scilit:

• Detailed Characterization of T Cell Responses to Herpes Simplex Virus-2 in Immune Seronegative Persons
  The Journal of Immunology, 2010
• Phase I Study of a Herpes Simplex Virus Type 2 (HSV-2) DNA Vaccine Administered to Healthy, HSV-2-Seronegative Adults by a Needle-Free Injection System
  Clinical and Vaccine Immunology, 2008
• DNA vaccines: ready for prime time?
  Nature Reviews Genetics, 2008
• Recombinant Vesicular Stomatitis Virus Vectors Expressing Herpes Simplex Virus Type 2 gD Elicit Robust CD4⁺Th1 Immune Responses and Are Protective in Mouse and Guinea Pig Models of Vaginal Challenge
  Journal of Virology, 2006
• Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.
  Journal of Clinical Investigation, 1998
• Herpes Simplex Viruses
  Clinical Infectious Diseases, 1998
• Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.
  Journal of Clinical Investigation, 1997
• Liposomes as Carriers of Peptide Antigens: Induction of Antibodies and Cytotoxic T Lymphocytes to Conjugated and Unconjugated Peptides
  Immunological Reviews, 1995
• Herpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth.
  Journal of Clinical Investigation, 1992
• Recurrences after Oral and Genital Herpes Simplex Virus Infection
  New England Journal of Medicine, 1987